Bora CDMO Bora CDMO

X

Find Radio Compass News for Naloxegol Oxalate

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

left grey arrow
right gray arrow
  • TABLET;ORAL - EQ 12.5MG BASE
  • TABLET;ORAL - EQ 25MG BASE

https://www.prnewswire.com/news-releases/redhill-biopharma-and-healthcare-royalty-agree-to-extinguish-all-redhills-debt-obligations-in-exchange-for-movantik-301739194.html

PR NEWSWIRE
06 Feb 2023

https://www.businesswire.com/news/home/20221124005096/en/Gr%C3%BCnenthal-and-Kyowa-Kirin-International-Announce-Joint-Venture-Collaboration-for-Established-Medicines-Portfolio

BUSINESSWIRE
25 Nov 2022

https://www.prnewswire.com/news-releases/redhill-biopharma-presenta-tres-nuevos-analisis-de-los-datos-de-movantik-en-painweek-2021-824281970.html

PRNEWSWIRE
08 Sep 2021

https://www.prnewswire.com/news-releases/redhill-biopharma-presents-three-new-analyses-of-movantik-data-at-painweek-2021-301370121.html

PRNEWSWIRE
07 Sep 2021

http://www.pharmabiz.com/NewsDetails.aspx?aid=122189&sid=2

PHARMABIZ
02 Apr 2020

http://www.pharmatimes.com/news/az_licences_movantik_rights_to_redhill_1334146

Selina McKee PHARMA TIMES
01 Apr 2020

https://www.fiercepharma.com/pharma/astrazeneca-offloads-most-global-rights-for-constipation-med-movantik

K. Blankenship FIERCE PHARMA
26 Feb 2020

https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM293268.pdf

FDA
12 Dec 2018

https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-bosulif-203341-bosutinib-extended-release-tablets-1544700163.pdf

FDA
12 Dec 2018

https://www.fiercepharma.com/marketing/bristol-myers-squibb-looks-for-opdivo-convenience-edge-new-four-week-dosing

Carly Helfand FIERCE PHARMA
06 Mar 2018

http://www.fiercebiotech.com/biotech/purdue-inks-shionogi-collab-constipation-med-as-it-awaits-fda-approval

Ben Adams FIERCE BIOTECH
19 Dec 2016

http://www.fiercepharma.com/pharma/daiichi-caps-layoffs-drive-by-melding-nj-ops-into-one-smaller-hq

Tracy Staton FIERCE PHARMA
25 Apr 2016

http://www.fiercepharma.com/story/astrazeneca-and-daiichi-sankyo-field-backlash-over-super-bowl-oic-awareness/2016-02-12

Beth Snyder Bulik FIERCE PHARMA
12 Feb 2016

http://www.fiercepharma.com/story/beleaguered-daiichi-sankyo-shuttering-german-antibody-business/2015-12-08

Emily Wasserman FIERCE PHARMA
08 Dec 2015

http://www.pharmatimes.com/Article/15-12-08/Five_medicines_cleared_for_use_by_NHS_Scotland.aspx?

Selina McKee PHARMATIMES
07 Dec 2015

http://www.biospectrumindia.com/biospecindia/features/222884/opioid-induced-constipation-treatment-market-boom-usd650-mn-2019

BioSpectrum Bureau BIOSPECTRUM INDIA
02 Dec 2015

http://www.fiercepharmamarketing.com/story/abbvies-humira-repeats-joined-bms-opdivo-leading-tv-spending-october/2015-11-18

Beth Snyder Bulik FIERCE PHARMA MARKETING
18 Nov 2015

http://www.fiercepharma.com/story/daiichi-shells-out-200m-plus-help-astrazeneca-launch-movantik/2015-03-19

Tracy Staton FIERCE PHARMA
20 Mar 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY